Radon Exposure Linked to CHIP Risk for Women With Ischemic Stroke

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Jan. 4, 2024 -- Radon exposure is associated with an increased risk for clonal hematopoiesis of indeterminate potential (CHIP) among postmenopausal women with ischemic stroke, according to a study published online Jan. 3 in Neurology.

Kurtis M. Anthony, M.P.H., from the Gillings School of Global Public Health at the University of North Carolina in Chapel Hill, and colleagues estimated the risk for CHIP related to radon by linking geocoded addresses of 10,799 Women's Health Initiative Trans-Omics for Precision Medicine participants to U.S. Environmental Protection Agency-predicted, county-level, indoor average screening radon concentrations, categorized as zones 1, 2, and 3 (>4, 2 to 4, and <2 pCi/L, respectively). CHIP was defined as the presence of one or more leukemogenic driver mutations with variant allele frequency >0.02.

The researchers found that 9.0, 8.4, and 7.7 percent of participants had CHIP in zones 1, 2, and 3, respectively. Zones 2 and 1 were associated with a higher estimated risk for CHIP relative to zone 3 among participants with ischemic stroke (1.39 and 1.46, respectively), but not among those with hemorrhagic stroke or those without stroke. Among Trial of ORG 10172 in Acute Stroke Treatment subtyped cardioembolism or other ischemic etiologies, the corresponding estimates were particularly high, but estimates were not significantly increased for small vessel occlusion.

"In conclusion, although the results do not support an association between radon and CHIP among postmenopausal women overall, they do suggest an association between radon and CHIP among participants with ischemic stroke," the authors write.

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-05 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords